Lopid and Nitro-dur drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Lopid (gemfibrozil) and Nitro-dur (nitroglycerin). Common drug interactions include weight increased among females and rhabdomyolysis among males.
The phase IV clinical study analyzes what interactions people have when they take Lopid and Nitro-dur. It is created by eHealthMe based on reports of 26 people who take the same drugs from the FDA, and is updated regularly.
What is Lopid?
Lopid has active ingredients of gemfibrozil. It is often used in high blood cholesterol. eHealthMe is studying from 9,700 Lopid users. Check the latest studies of Lopid.
What is Nitro-dur?
Nitro-dur has active ingredients of nitroglycerin. eHealthMe is studying from 2,414 Nitro-dur users. Check the latest studies of Nitro-dur.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
26 people who take Lopid and Nitro-dur together, and have interactions are studied.

What are the common drug interactions of Lopid and Nitro-Dur, by gender? *:
female:
- Weight increased
- Anaphylactic reaction (serious allergic reaction)
- Anuria (failure of the kidneys to produce urine)
- Bone pain
- Cardiac disorder
- Cardiac enzymes increased
- Chest pain
- Chest pressure sensation (feeling of pressure on chest)
- Chills (felling of cold)
- Colitis (inflammation of colon)
male:
- Rhabdomyolysis (a condition in which damaged skeletal muscle tissue breaks down)
- Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
- Renal failure (kidney dysfunction)
- Abdominal distension
- Anaemia (lack of blood)
- Anxiety
- Arthralgia (joint pain)
- Asthenia (weakness)
- Back pain
- Bulimia nervosa (eating disorder characterized by recurrent binge eating, followed by compensatory behaviours)
What are the common drug interactions of Lopid and Nitro-Dur, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
- Cardiomegaly (increased size of heart than normal)
- Cardiovascular disorder (heart diseases)
- Chest pain
- Coronary artery disease (plaque building up along the inner walls of the arteries of the heart, which narrows the arteries and restricts blood flow to the heart)
- Cough
- Depression
- Dermatitis (inflammation of the skin resulting from direct irritation by an external agent or an allergic reaction to it)
- Discomfort
- Drug maladministration
- Dry skin
40-49:
- Anxiety
- Apnoea (suspension of external breathing)
- Bradycardia (abnormally slow heart action)
- Choking (mechanical obstruction of the flow of air from the environment into the lungs)
- Coronary artery disease (plaque building up along the inner walls of the arteries of the heart, which narrows the arteries and restricts blood flow to the heart)
- Depression
- Gasping (laboured breathing)
- Gastro-oesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
- Hypopnoea (decrease in the breathing rate)
- Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development)
50-59:
- Rhabdomyolysis (a condition in which damaged skeletal muscle tissue breaks down)
- Cough
- Palpitations (feelings or sensations that your heart is pounding or racing)
- Paralysis
60+:
- Rhabdomyolysis (a condition in which damaged skeletal muscle tissue breaks down)
- Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
- Sepsis (a severe blood infection that can lead to organ failure and death)
- Anaphylactic reaction (serious allergic reaction)
- Anuria (failure of the kidneys to produce urine)
- Arthralgia (joint pain)
- Chills (felling of cold)
- Dehydration (dryness resulting from the removal of water)
- Dyspnoea (difficult or laboured respiration)
- Dysuria (painful or difficult urination)
What are the existing conditions these people have? *
- High Blood Pressure: 2 people, 7.69%
* Approximation only. Some reports may have incomplete information.
Do you take Lopid and Nitro-dur?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Lopid and Nitro-dur:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Lopid:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Nitro-dur:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Lopid and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Nitro-dur and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on gemfibrozil and nitroglycerin (the active ingredients of Lopid and Nitro-dur, respectively), and Lopid and Nitro-dur (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Flecainide Acetate and Death for Men aged 60+ - now
- Could Aripiprazole cause Gastrointestinal Perforation? - 2 seconds ago
- Hiv Infection and Hepatitis C - 4 seconds ago
- Could Zoloft cause Drug Exposure During Pregnancy? - 7 seconds ago
- Could Sotret cause Back Pain Aggravated? - 7 seconds ago
- Sulfamethoxazole And Trimethoprim vs. Levaquin, side effect and effectiveness comparison - 7 seconds ago
- Flecainide Acetate and Sudden Death for Men aged 60+ - 8 seconds ago
- Flecainide Acetate and Death Sudden for Men aged 60+ - 9 seconds ago
- Citalopram Hydrobromide and Anxiolytic Therapy for Women aged 60+ - 9 seconds ago
- Citalopram Hydrobromide and Anxiety And Stress for Women aged 60+ - 9 seconds ago